Ownership history in Fourth Sail Capital LP Β· 9 quarters on record
This page tracks every 13F SEC filing in which Fourth Sail Capital LP reported a position in BIOCERES CROP SOLUTIONS CORP (BIOX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Fourth Sail Capital LP underperformed the S&P 500 by β112.3% annually on this BIOX position. Timing score: 0% (0/5 decisions correct). Average cost basis: $8.28. Maximum drawdown during holding period: β89.7%.
β Significantly underperformed the S&P 500 by 112.3% ann.
7 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
0 of 5 add/trim decisions correct
Best entry: $4.57 (2025 Q1) Β· Worst: $12.66 (2024 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
6 adds Β· 1 trim. Bought during 4 of 7 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.91% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size